Form 4 for SNPS Synopsys
Accepted 2024-05-29 00:00:00 ET · period of report 2024-05-24 · accession 0001517737-24-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-29 | 2024-05-24 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | S - Sale+OE | $582.90 | -1,239 | 20.0K | -6% | -$722.2K |
| DM | 2024-05-29 | 2024-05-24 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | M - OptEx | $299.22 | +1,239 | 20.3K | +6% | +$370.7K |
| DM | 2024-05-29 | 2024-05-24 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | M - OptEx | $0.00 | -1,239 | 3,352 | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-24 | S | D | 304 | $582.90 | 20,000 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-24 | M | A | 366 | $354.48 | 20,366 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-24 | S | D | 366 | $582.90 | 20,000 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-24 | M | A | 569 | $234.17 | 20,569 | D | — | — | |
| 5 | Common | Common Stock | 2024-05-24 | M | A | 304 | $354.45 | 20,304 | D | — | — | |
| 6 | Common | Common Stock | 2024-05-24 | S | D | 569 | $582.90 | 20,000 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-05-24 | M | D | 366 | $0.00 | 2,563 | D | $354.48 · 2022-12-09 to 2028-12-09 | 366 Common Stock | (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-05-24 | M | D | 569 | $0.00 | 1,709 | D | $234.17 · 2021-12-10 to 2027-12-10 | 569 Common Stock | (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-05-24 | M | D | 304 | $0.00 | 3,352 | D | $354.45 · 2024-02-17 to 2030-02-17 | 304 Common Stock | (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |